Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-02-14FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application to market a generic product containing four amphetamine salts (dextroamphetamine …
-
FDA approval · 2022-02-14FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA granted supplemental approval for Teva Pharmaceuticals USA, Inc. to market a generic combination product containing four amphetamine…
-
FDA approval · 2022-02-14FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for the combination of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfat…
-
FDA approval · 2022-02-10FDA Approved: AMPHETAMINE SULFATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Amphetamine Sulfate (amphetamine) by Amneal Pharmaceuticals NY LLC under ANDA211139, marking a r…
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study [Phase 1, Phase 2]
Clinical trial updates for the MADDY study evaluating micronutrients in youth with ADHD across Phase 1 and Phase 2, with completed status an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: The Effects of ADHD Medication (TEAM) Study [Phase 4]
Phase 4 trial updating effects of ADHD medication in children; results posted after completion.
-
FDA approval · 2022-01-31FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's generic combination of four amphetamine salts (dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroam…
-
FDA label_change · 2022-01-06FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Strattera (atomoxetine hydrochloride) from Eli Lilly and Company, updating the drug's labeli…
-
FDA approval · 2021-12-28FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved a new generic combination amphetamine product (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, …
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD [Phase 3]
Phase 3 clinical trial evaluating long-term safety and efficacy of ORADUR-Methylphenidate in children and adolescents with ADHD has complete…
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder [Phase 4]
Phase 4 trial evaluating adjunctive cariprazine for adults with attention deficit hyperactivity disorder is reported as an update with no cu…
-
FDA approval · 2021-12-08FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic dexmethylphenidate hydrochloride as an original application, expanding access to ADHD treatment…
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD [Phase 3]
Phase 3 trial evaluating ORADUR-Methylphenidate for safety and efficacy in children and adolescents with ADHD has been completed.
-
CLINICAL_TRIALS withdrawal · 2021-12-02Clinical Trial Update: Event Rate and Effects of Stimulants in ADHD [Phase 3]
A Phase 3 ADHD trial was withdrawn, providing no conclusive results for stimulant effects.
-
FDA approval · 2021-11-26FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Original Application (Golden State Medical Supply, Inc.)
FDA approved a generic drug product comprising four amphetamine salts (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine …
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD [Phase 4]
Phase 4 pharmacokinetic study of methylphenidate hydrochloride extended-release capsules in children aged 4 to under 6 with ADHD completed; …
-
FDA approval · 2021-11-23FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Original Application (Par Health USA, LLC)
The FDA approved an extended-release dexmethylphenidate hydrochloride product from Par Health USA, LLC through an Original Application (ANDA…
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Development of a Mobile App for an Executive Functioning Intervention for Adolescents [NA]
A completed clinical trial evaluating a mobile app for executive functioning intervention in adolescents with ADHD symptoms; results posted …
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT [Phase 2]
Phase 2 clinical trial assessing lisdexamfetamine for ADHD and related SCT has been completed with posted results.
-
CLINICAL_TRIALS withdrawal · 2021-11-15Clinical Trial Update: Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population [Phase 3]
Phase 3 trial evaluating melatonin for youth with ADHD and initial insomnia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 trial update on Centanafadine sustained-release for adults with ADHD completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 clinical trial update for PDC-1421 in adults with ADHD; study completed with results posted.
-
FDA approval · 2021-11-04FDA Approved: DYANAVEL XR — Original Application (NextWave Pharmaceuticals, Inc)
FDA approves DYANAVEL XR under original NDA for the treatment of attention-deficit/hyperactivity disorder. The product is developed by NextW…
-
FDA approval · 2021-11-02FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2021-11-01FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for dexmethylphenidate hydrochloride from Par Health USA, LLC. Dexmethylphenidate hydrochloride …